very odd…. So odd. I’m borderline delusional enough to hope:
1. MPS data is so good we need more analysis….
2. We are too busy dealing with medium sized pharma companies in the non binding stage, for deals for OA and MPS, progressing to binding/final offer stage.
3. Our workforce is preparing for the regulatory meetings that loom large.
PAR. SP, page-709
-
- There are more pages in this discussion • 278 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.0¢ |
Change
-0.005(2.13%) |
Mkt cap ! $80.45M | |||
| Open | High | Low | Value | Volume |
| 23.8¢ | 24.0¢ | 23.0¢ | $124.1K | 527.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 32320 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 28026 | 2 |
View Market Depth
| Last trade - 16.10pm 08/08/2024 (20 minute delay) ? |
| PAR (ASX) Chart |